Roger Ferrini, PhD, PMP, RAC-Drugs has a diverse background in the biotechnology and pharmaceutical industry. Roger currently serves as the Associate Director of Development at IgGenix, Inc, a position they have held since February 2023. Previously, they worked as a Senior Project Manager at Sentynl Therapeutics, Inc. from June 2021 to February 2023.
Before that, Roger was a Program Manager at Abzena from December 2020 to June 2021. Roger also spent several years at Bird Rock Bio, Inc., holding various roles including Consultant from January 2020 to January 2021, Head of Antibody Technologies, and Senior Director of GPCR Antibody Technologies.
Prior to their time at Bird Rock Bio, Roger worked at RuiYi, Inc. as the Director of GPCR Antibody Technologies, overseeing drug discovery collaborations. During their tenure, they managed various technical aspects of drug discovery collaborations, including the identification of therapeutic antibodies against GPCR targets. Roger also played a significant role in overseeing the development of multiple drugs for RuiYi, Inc.
Other notable positions in Roger's career include Scientist/Senior Scientist at Anaphore, Inc. from 2009 to 2012, Post Doctoral Fellow at Harvard Medical School from 2006 to 2009, and Graduate Student at Howard Hughes Medical Institute/UCLA from 1998 to 2005. Roger began their career as a Research Technician at Harvard Medical School from 1995 to 1998.
Roger Ferrini, PhD, PMP, RAC-Drugs has a strong educational background in the field of biology and immunology. Roger began their education at Bates College, where they obtained a Bachelor of Science degree in Biology from 1990 to 1994. Roger then pursued further studies at UCLA, where they earned their Ph.D. in Immunology from 1998 to 2005.
After completing their Ph.D., Roger Ferrini went on to pursue post-doctoral training at Harvard Medical School. Roger served as a Post Doctoral Fellow at Harvard Medical School from 2006 to 2009, although the specific field of study during this period is not specified.
In addition to their academic achievements, Roger Ferrini has obtained several certifications to enhance their professional skills. Roger earned a Project Management Professional (PMP) certification from the Project Management Institute in December 2020. Roger also obtained a Regulatory Affairs Certificate in Pharmaceuticals from the Regulatory Affairs Certification Program in September 2019. Furthermore, they hold a Certificate of Achievement in Alliance Management (CA-AM) from the Association of Strategic Alliance Professionals, which they obtained in October 2020. Most recently, in August 2021, they completed a course on Presenting to Senior Executives at LinkedIn.
Based on the information provided, it is evident that Roger Ferrini has a well-rounded educational background and has also sought additional certifications to enhance their expertise in project management, regulatory affairs, and alliance management.
Sign up to view 0 direct reports
Get started
This person is not in any teams